Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 06, 2025
Delay to timely treatment in locally advanced cervical cancer: insurance inequities in access to gynecologic oncology.
Journal: American journal of obstetrics and gynecology
Published: October 01, 2024
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.
Journal: Nature communications
Published: September 18, 2024
Leveraging sequences missing from the human genome to diagnose cancer.
Journal: Communications medicine
Published: June 17, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.
Journal: JCO precision oncology
Published: June 12, 2024
Exploring the relationship between language, postoperative pain, and opioid use.
Journal: AJOG global reports
Published: April 29, 2024
The role of race/ethnicity and age in clinical trial knowledge among patients with gynecologic malignancy.
Journal: Gynecologic oncology
Published: March 27, 2024
Evidence-based prescribing of opioids after laparotomy: A quality-improvement initiative in gynecologic oncology.
Journal: Gynecologic oncology reports
Published: March 05, 2024
Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum.
Roadmap to safety: a single center study of evidence-informed approach to placenta accreta spectrum.
Journal: Frontiers in surgery
Published: December 01, 2023
The past, present, and future of opioid prescribing: Perioperative opioid use in gynecologic oncology patients after laparotomy at a single institution from 2012 to 2021.
Journal: Gynecologic oncology reports
Published: March 13, 2023
A T-cell engaging bispecific antibody with a tumor-selective bivalent folate receptor alpha binding arm for the treatment of ovarian cancer.
Journal: Oncoimmunology
Published: August 26, 2022
Last Updated: 09/26/2026